This collaboration is expected to benefit over 400 children, providing them with a chance at a better tomorrow HCG Cancer Centre Bangalore announced the signing of a Memorandum of Understanding (MoU) with Samraksha – Thalassemia Day Care Centre. The agreement focuses on providing subsidized Bone Marrow
Revenue for Q3FY25 of INR 5,586 Million, a growth of 19% (y-o-y); 9MFY25 revenue stood at INR 16,377 Million, a growth of 16% (y-o-y) EBITDA for Q3FY25 of INR 923 Million, a growth of 15% (y-o-y) with 16.5% Margins and PAT for Q3FY25 of INR 70
This fun and inclusive Pickleball tournament brought together clinicians, cancer champions, care givers and cancer support groups Observing World Cancer Day, HCG Cancer Centre Bangalore organized a fun and inclusive Pickleball Tournament for cancer champions, clinicians and care givers. The event, aligned with the global theme of
Innovative, data-driven program to accelerate cancer research in South Asia HealthCare Global Enterprises Limited (HCG), one of the largest cancer care networks in India, is collaborating with Accenture (NYSE: ACN) to accelerate cancer research and care through the use of advanced AI, including generative AI and deep
- 400 Participants Join the Ride to Promote Early Detection and Health Screenings for Men In observance of Prostate Cancer Awareness Month, HCG Cancer Centre Bengaluru successfully hosted the ‘Cyclothon @ Namma Bengaluru’ today. This 6.5-kilometre cycling event aimed to raise awareness about prostate cancer and encourage men
Healthcare Global Enterprises Limited (HCG), India’s largest cancer care network, successfully concluded the 5th Annual National Nursing Conference 2024 Transforming Nursing for Future Healthcare- A New Insight today at Hotel Grand Magrath, Bangalore. The event was graced by distinguished guests, including Shri Dinesh Gundu Rao, Minister of Health &
Collaboration to validate next-generation tests for detection of primary and recurrent/metastatic cancer and personalized treatment response prediction. Partnership aims to enhance precision oncology through advanced novel biomarker-driven diagnostics. HealthCare Global Enterprises Limited (HCG), India’s leading provider of cancer care announced a research collaboration with Trucan
Community Gathers in Support of Early Detection and Screening with 180 Women Riders Leading the Charge In observance of Breast Cancer Awareness Month, HCG Cancer Centre Bengaluru successfully hosted the ‘Pink Women’s Bikeathon 2024,’ a 10-kilometer all women bike rally aimed at raising awareness for breast
HCG Cancer Centre Bengaluru is proud to announce the launch of the CyberKnife S7 System, a fully automated, AI-driven treatment delivery system with real-time motion adaptation, marking a significant advancement in the treatment of both cancerous and non-cancerous tumors. The system was unveiled by Dr.
Revenue for Q4 FY24 of INR 4,946 Million, a growth of 12% (y-o-y) and for FY24 of INR 19,121 Million, a growth of 13% (y-o-y) EBITDA for Q4 FY24 of INR 941 Million, a growth of 21% (y-o-y) and EBITDA for FY24 of INR 3,374 Million,
